Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder - Bymaster, Frank P; Katner, Jason S; Nelson, David L; Hemrick-Luecke, Susan K; Threlkeld, Penny G; Heiligenstein, John H; Morin, S.Michelle; Gehlert, Donald R; Perry, Kenneth W (Neuropsychopharmacology (New York, N.Y.), 2002)
Keywords: Amphetamines; Animals; Atomoxetine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity - drug therapy; Attention Deficit Disorder with Hyperactivity - metabolism; Attention Deficit/Hyperactivity Disorder; Biological and medical sciences; Catecholamines; Dopamine; Dopamine - metabolism; Dopamine - secretion; Drug abuse; Drug Synergism; Drug therapy; Fos expression; Humans; Hyperactivity; Insomnia; Laboratories; Male; Medical sciences; Methylphenidate; Microdialysis; Neuropharmacology; Norepinephrine; Norepinephrine - metabolism; Norepinephrine - secretion; Pharmacology. Drug treatments; Prefrontal Cortex - drug effects; Prefrontal Cortex - metabolism; Prefrontal Cortex - secretion; Propylamines - pharmacology; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease); Psychology. Psychoanalysis. Psychiatry; Psychopharmacology; Rats; Rats, Sprague-Dawley; Reboxetine; United States--US; Indianapolis Indiana; Reboxetine; Dopamine; Microdialysis; Atomoxetine; Norepinephrine; Fos expression; Attention Deficit/Hyperactivity Disorder; Methylphenidate; Rat; CNS stimulant; Hyperactivity; Psychotropic; Rodentia; Molecular interaction; Prefrontal cortex; Molecular marker; Catecholamine; Reuptake inhibitor; Vertebrata; Tomoxetine; Mammalia; Attentional disorder; Animal; Drug interaction; Mechanism of action; Comparative study